Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of January 5, 2025 • 7:00 PM ET
As of January 5, 2025 • 7:00 PM ET
Date/Time | Source | News Release |
---|---|---|
09/23/2022 09:39 AM EDT | SeekingAlpha | CytRx to rename as LadRx |
09/07/2022 10:26 AM EDT | SeekingAlpha | European patent office awards CytRx patent for LADR platform |
03/09/2022 12:24 PM EST | SeekingAlpha | CytRx to absorb subsidiary Centurion BioPharma; former CEO retires from board |
12/28/2021 11:53 AM EST | SeekingAlpha | ImmunityBio pares gains following aldoxorubicin data in cancer |
11/12/2021 08:30 AM EST | SeekingAlpha | CytRx reports Q3 results |
10/14/2021 03:56 PM EDT | SeekingAlpha | CytRx Corporation (CYTR) Investor Presentation - Slideshow |
09/07/2021 07:33 PM EDT | SeekingAlpha | No More Dark Stocks? Invest In Nanocaps Instead |
08/24/2021 09:05 AM EDT | SeekingAlpha | Orphazyme's arimoclomol shows meaningful treatment effect in late-stage NPC study |
07/13/2021 08:36 AM EDT | SeekingAlpha | CytRx inks securities purchase agreement for $10M |
06/22/2021 07:31 AM EDT | SeekingAlpha | Orphazyme: Game Over, Man |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.